SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001144204-14-034073
Filing Date
2014-05-29
Accepted
2014-05-29 09:10:54
Documents
6
Period of Report
2014-05-28
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 1.02: Termination of a Material Definitive Agreement
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K v379970_8k.htm 8-K 25924
2 EXHIBIT 10.1 v379970_ex10-1.htm EX-10.1 196541
3 EXHIBIT 10.2 v379970_ex10-2.htm EX-10.2 78307
4 EXHIBIT 10.3 v379970_ex10-3.htm EX-10.3 12863
5 EXHIBIT 99.1 v379970_ex99-1.htm EX-99.1 8522
6 GRAPHIC image_001.jpg GRAPHIC 5246
  Complete submission text file 0001144204-14-034073.txt   330776
Mailing Address 621 N. SHADY RETREAT ROAD DOYLESTOWN PA 18901
Business Address 621 N. SHADY RETREAT ROAD DOYLESTOWN PA 18901 2153450919
ProPhase Labs, Inc. (Filer) CIK: 0000868278 (see all company filings)

IRS No.: 232577138 | State of Incorp.: NV | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 000-21617 | Film No.: 14874447
SIC: 2834 Pharmaceutical Preparations